Profile
Nils Anders Haegerstrand is currently the Chief Executive Officer at Annexin Pharmaceuticals AB and the Chief Executive Officer at Spatial Transcriptomics Holding AB. Previously, he worked as the Global Manager at AstraZeneca PLC from 1999 to 2000.
He also held positions as the Manager-Drug Discovery & Development at Karolinska Institutet, the Chief Executive & Scientific Officer at Newron Sweden AB, and the Manager-Drug Discovery & Development at Astra Pain Control AB. Dr. Haegerstrand obtained a doctorate degree from Karolinska Institutet.
Nils Anders Haegerstrand active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | 2018-12-31 |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Provides cells analysis in morphological context to genetic activity | Chief Executive Officer | - |
Former positions of Nils Anders Haegerstrand
| Companies | Position | End |
|---|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Chief Executive Officer | 2017-05-31 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 1999-12-31 |
Astra Pain Control AB | Corporate Officer/Principal | - |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Nils Anders Haegerstrand
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Astra Pain Control AB | |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Provides cells analysis in morphological context to genetic activity | Commercial Services |
- Stock Market
- Insiders
- Nils Anders Haegerstrand
















